Admedus Immunotherapies

Learn More Global Healthcare Company


Admedus Tissue Engineering

Learn More Healthcare Innovations - Baby Tissue Engineering


Admedus Medical Products

Learn More Hospital Equipment Australia

News & Media

< >

Admedus 2017 Annual General Meeting webinar

The investor webinar from our AGM on 16 November 2017 is now available to view via this link – AHZ – AGM 16 November 2017

November 17th 2017

Find out more

Admedus announces facility agreement with Partners for Growth

Admedus Ltd today announced that it has entered into an agreement with Partners for Growth (PFG) for a secured debt facility of up to AUD $10 million. Based in the San Francisco Bay area, PFG is a partnership that provides capital funding debt solutions to private and public technology and life science companies. Read full […]

October 26th 2017

Find out more

Admedus TAVR project on track with new IP applications

Admedus Ltd today announced that it has submitted IP applications relating to the development of a new Transcatheter Aortic Valve Replacement (TAVR) device. Read the full ASX statement here.

October 24th 2017

Find out more

New neck and head cancer treatment a step closer to trials

As reported widely across Australian media outlets, Admedus Immunotherapies recently received a $250,000 Government grant from the Advance Queensland Ignite Ideas Fund to support human clinical trials, led by Professor Ian Frazer, of a new vaccine that could be used to treat head and neck cancer. Find a copy of the story on,  7 News  or Brisbane Times. Read the full […]

October 23rd 2017

Find out more

Update on experts’ meeting (advisory board)

Recently, at the Admedus advisory board meeting run consecutively with the EACTS annual congress in Vienna, doctors validated the clinical benefits/medical utility and value to patients of our single piece aortic valve (vs. three piece leaflet from the competitors) in both the TAVR and SAVR settings. Our development work in this area continues as we […]

October 13th 2017

Find out more

Upcoming Events


May 24th 2018 See event details

Welcome to Admedus

Admedus is a global healthcare company that develops, commercialises and distributes next generation medical technologies and devices. Our mission is to provide patients around the world with a better quality of life through access to our leading medical solutions and products.

Learn More

CardioCel regenerative tissue scaffold

CardioCel® is a superior cardiovascular bioscaffold used to repair and reconstruct heart defects.

Read More

Our range of medical products and devices combine quality and value with the very latest technology

View our full range of products